Airsculpt Technologies vs Petmed Express
Petmed Express is the larger business, with $179m of revenue in fiscal 2026 against $152m for Airsculpt Technologies (1.2 times as much). Airsculpt Technologies grew faster (-15.8% against -21.1%). Airsculpt Technologies kept more of each dollar of sales as profit: a net margin of -7.7% against -32.0%. Petmed Express carries less debt relative to equity (0.0% against 64.9%).
| Latest fiscal year | Airsculpt TechnologiesAIRS, 2025 | Petmed ExpressPETS, 2026 |
|---|---|---|
| Revenue | $152m | $179m |
| Revenue growth | -15.8% | -21.1% |
| Net income | −$11.7m | −$57.3m |
| Operating margin | -7.6% | -32.8% |
| Net margin | -7.7% | -32.0% |
| Return on equity | -14.1% | -100.4% |
| Free cash flow | $692,000 | −$33.0m |
| Cash | $8.4m | $21.4m |
| Total debt | $57.0m | $0 |
| Debt to equity | 64.9% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | 0.0% | 0.1% |
| Share buybacks | — | — |
| Employees | 330 | 189 |
| Market value | $118m | $26.1m |
| Price vs our value range | — | — |
| Moat score | — | 54 (Moderate) |
| Insider trades, 12 months | 13 buys, 0 sales | 1 buys, 0 sales |